CNQ · BETR.CN
BetterLife Pharma Inc.
CA$0.25+CA$0.01 (+4.17%)
BetterLife Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.65% below the high.
Loading market information…
OTC · GVDI · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Golden Valley Development, Inc’s quoted price sits in the lower half of its reported 52-week range, 74.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Golden Valley Development, Inc. operates through its subsidiaries, primarily focusing on the creation and distribution of proprietary products for both the healthcare and household consumer sectors. Noteworthy examples include Percuguard and Cutstop, which are specialized finger safety guards designed to protect fingers and thumbs from unintentional cuts caused by knives and other sharp implements. Additionally, the company provides media consulting services, where it identifies and facilitates partnerships among businesses, investors, and influential individuals in the entertainment and sports industries for the development of collaborative marketing and entertainment ventures. Golden Valley Development, Inc. was established in 2004 and is headquartered in Clearwater, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.25+CA$0.01 (+4.17%)
BetterLife Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.65% below the high.
$0.56$0.00 (0.0%)
Crescita Therapeutics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.5% below the high.
CA$0.04CA$0.00 (0.0%)
AI/ML Innovations Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.94% below the high.
£0.02+£0.00 (+15.75%)
Proteome Sciences plc’s quoted price sits in the lower half of its reported 52-week range, 61.59% below the high.
$0.83+$0.06 (+8.02%)
Curative Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.32% below the high.
CA$0.03CA$0.00 (0.0%)
Christina Lake Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
$0.01$0.00 (0.0%)
Odyssey Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.25% below the high.
$0.00$0.00 (0.0%)
Ayr Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.48% below the high.
